Posted inMarket
Legend Biotech Stock Maintained at Buy by H.C. Wainwright
H.C. Wainwright maintains its buy rating for Legend Biotech, highlighting strong market positioning and ongoing growth potential.
Posted inBusiness Insights
Kedaara Capital Leads Bid for Controlling Stake in Olive PharmaScience
Private equity firm Kedaara Capital has emerged as the frontrunner to acquire a significant stake in Olive PharmaScience, a strategic move that industry analysts value at approximately ₹4,500 crore. The…
